$1.12
1.82% today
Nasdaq, Jun 28, 07:45 pm CET
ISIN
US6085501095
Symbol
MTEM
Sector
Industry

Molecular Templates, Inc. Share price

$1.10
-0.15 12.00% 1M
-2.70 71.05% 6M
-2.63 70.51% YTD
-5.80 84.06% 1Y
-124.30 99.12% 3Y
-115.90 99.06% 5Y
-637.45 99.83% 10Y
Nasdaq, Closing price Thu, Jun 27 2024
ISIN
US6085501095
Symbol
MTEM
Sector
Industry

Key figures

Market capitalization $7.24m
Enterprise Value $12.10m
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.38
P/S ratio (TTM) P/S ratio 0.23
P/B ratio (TTM) P/B ratio 1.01
Sales growth (TTM) Sales growth -33.68%
Turnover (TTM) Turnover $31.76m
EBIT (operating result TTM) EBIT $-22.30m
Free cash flow (TTM) Free cash flow $-27.72m
Cash position $6.78m
EPS (TTM) EPS $-4.36
P/E ratio expected negative
P/S ratio expected 0.59
EV/Sales expected 0.99
Short interest 4.21%
Show more

Is Molecular Templates, Inc. a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.

Molecular Templates, Inc. Share analysis

Unlock scores for free

Analyst opinions

1 Analyst has issued a forecast Molecular Templates, Inc.:

1x Buy
100%

Analyst opinions

1 Analyst has issued a forecast Molecular Templates, Inc.:

Buy
100%

Financial data from Molecular Templates, Inc.

Profit and loss account P&L | Balance sheet | Cash flow


Quarter TTM Annually
Mar '24
+/-
%
32 32
34% 34%
100%
- Direct costs 5.93 5.93
26% 26%
19%
26 26
35% 35%
81%
- Selling and administrative expenses 4.96 4.96
41% 41%
16%
- Research and development costs 37 37
53% 53%
117%
-16 -16
66% 66%
-52%
- Depreciation and amortization 5.93 5.93
26% 26%
19%
EBIT (operating result) EBIT -22 -22
60% 60%
-70%
Net profit -18 -18
69% 69%
-58%

Figures in millions USD.

Don't miss a thing! We will send you all news about the Molecular Templates, Inc. share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Molecular Templates, Inc. Share News

Neutral
GlobeNewsWire
25 days ago
AUSTIN, Texas, June 03, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage company focused on the discovery and development of targeted biologic therapeutics with unique mechanisms of action (engineered toxin bodies or “ETBs”) for cancer and immune-mediated disease, today provided an update on its clinical-stage programs.
Neutral
GlobeNewsWire
about one month ago
AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action, today reported financial results ...
Neutral
GlobeNewsWire
3 months ago
AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action for cancer, today announced that...
More Molecular Templates, Inc. News

Company profile

Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded by Eric E. Poma, Jean Gariépy and Leigh Revers on October 17, 2001 and is headquartered in Austin, TX.

Head office United States
CEO Eric Poma
Employees 62
Founded 2000
Website www.mtem.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now